Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

New genetic discoveries may lead to better treatments for alopecia areata.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Keratinocyte adhesion problems can cause skin and hair disorders.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Hair conditions can be linked to diabetes and affect psychological health.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Apoptosis in hair follicles varies by growth phase, with TGF-β possibly starting the catagen phase.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Abnormal ECM and immune cell interactions can cause skin diseases.

CD44 variant changes start alopecia areata, but don't maintain it.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

More research is needed to understand and treat morphea effectively.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.